GARY S ROUBIN
CIK 1162533 · last filed 2026-05-08
GARY S ROUBIN is a corporate insider who has filed 25 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider bought $106.2K of NSPR on May 8, 2026. Across all open-market trades the lifetime net is +$1.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $609.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$609.2K
4
25
$1.06M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NSPR | Director | 834,478 | $0.73 | $609.2K | $500.5K | 16 | 2026-05-08 |
| InspireMD, Inc. (NSPRZ) Delisted | Director | 128,694 | $0.01 | $1.2K | $243.6K | 4 | 2021-12-30 |
| InspireMD, Inc. (NSPR.WS.B) Delisted | Director | 703,103 | $0.03 | $21.0K | $250.0K | 3 | 2021-04-21 |
| LIPID SCIENCES INC/ (LIPD) Delisted | Director | 119,523 | — | — | $70.3K | 2 | 2007-12-05 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-08 | NSPR | Buy (P) | +90,000 | $106.2K | EDGAR |
| 2026-01-16 | NSPR | Grant (A) | +88,053 | $0 | EDGAR |
| 2025-10-09 | NSPR | Grant (A) | +48,000 | $0 | EDGAR |
| 2025-08-01 | NSPR | Buy (P) | +41,322 | $100.0K | EDGAR |
| 2025-07-23 | NSPR | Exer (X) | +30,624 | $42.3K | EDGAR |
| 2025-01-10 | NSPR | Grant (A) | +32,491 | $0 | EDGAR |
| 2024-05-30 | NSPR | Exer (X) | +30,625 | $42.3K | EDGAR |
| 2024-01-25 | NSPR | Grant (A) | +29,032 | $0 | EDGAR |
| 2024-01-11 | NSPR | Grant (A) | +3,229 | $0 | EDGAR |
| 2023-12-04 | NSPR | Buy (P) | +50,000 | $126.5K | EDGAR |